Drug-induced liver injury: Twenty five cases of acute hepatitis following ingestion of Polygonum multiflorum thunb

Gut and Liver

Volumn 5, Issue 4, 2011, Pages 493-499

  Jung, Kyoung Ah ^a   Min, Hyun Ju ^a   Yoo, Seung Suk ^a   Kim, Hong Jun ^a   Choi, Su Nyoung ^a   Ha, Chang Yoon ^a   Kim, Hyun Jin ^a   Kim, Tae Hyo ^a   Jung, Woon Tae ^a   Lee, Ok Jae ^a   Lee, Jong Sil ^a   Shim, Sang Goon ^b  

^a Gyeongsang National University School of Medicine   (South Korea)

^b Sungkyunkwan University School of Medicine   (South Korea)

Author keywords

Drug induced liver injury; Hepatotoxicity; Polygonum multiflorum thunb

Indexed keywords

ALANINE AMINOTRANSFERASE; FALLOPIA MULTIFLORA EXTRACT; PLANT EXTRACT; UNCLASSIFIED DRUG;

ACUTE HEPATITIS; ADULT; AGED; ALANINE AMINOTRANSFERASE BLOOD LEVEL; ARTICLE; CLINICAL ARTICLE; DRUG INDUCED DISEASE; FALLOPIA MULTIFLORA; FEMALE; HISTOPATHOLOGY; HOSPITAL CARE; HUMAN; JAUNDICE; LIQUID; LIVER FAILURE; LIVER INJURY; LIVER TOXICITY; MALE; POWDER; TEA; TOXIC HEPATITIS;

EID: 81855184387     PISSN: 19762283     EISSN: None     Source Type: Journal    
DOI: 10.5009/gnl.2011.5.4.493     Document Type: Article

References (29)

1. Verma S, Kaplowitz N. Diagnosis, management and prevention of drug-induced liver injury. Gut 2009;58:1555-1564.
2. Biour M, Ben Salem C, Chazouillères O, Grangé JD, Serfaty L, Poupon R. Drug-induced liver injury; fourteenth updated edition of the bibliographic database of liver injuries and related drugs. Gastroenterol Clin Biol 2004;28:720-759. (Pubitemid 39318162)
3. Larrey D. Drug-induced liver diseases. J Hepatol 2000;32(1 Suppl):77-88. (Pubitemid 30123626)
4. Meier Y, Cavallaro M, Roos M, et al. Incidence of drug-induced liver injury in medical inpatients. Eur J Clin Pharmacol 2005;61:135-143. (Pubitemid 40674746)
5. Bagheri H, Michel F, Lapeyre-Mestre M, et al. Detection and incidence of drug-induced liver injuries in hospital: a prospective analysis from laboratory signals. Br J Clin Pharmacol 2000;50:479-484.
6. Sgro C, Clinard F, Ouazir K, et al. Incidence of drug-induced hepatic injuries: a French population-based study. Hepatology 2002;36:451-455. (Pubitemid 34810366)
7. MacGregor FB, Abernethy VE, Dahabra S, Cobden I, Hayes PC. Hepatotoxicity of herbal remedies. BMJ 1989;299:1156-1157. (Pubitemid 19266434)
8. Woolf GM, Petrovic LM, Rojter SE, et al. Acute hepatitis associated with the Chinese herbal product jin bu huan. Ann Intern Med 1994;121:729-735.
9. Gordon DW, Rosenthal G, Hart J, Sirota R, Baker AL. Chaparral ingestion: the broadening spectrum of liver injury caused by herbal medications. JAMA 1995;273:489-490.
10. Chitturi S, Farrell GC. Herbal hepatotoxicity: an expanding but poorly defined problem. J Gastroenterol Hepatol 2000;15:1093-1099.
11. Seeff LB. Herbal hepatotoxicity. Clin Liver Dis 2007;11:577-596, vii. (Pubitemid 47302344)
12. Stickel F, Egerer G, Seitz HK. Hepatotoxicity of botanicals. Public Health Nutr 2000;3:113-124. (Pubitemid 30666518)
13. Stickel F, Patsenker E, Schuppan D. Herbal hepatotoxicity. J Hepatol 2005;43:901-910. (Pubitemid 41414517)
14. But PP, Tomlinson B, Lee KL. Hepatitis related to the Chinese medicine Shou-wu-pian manufactured from Polygonum multiflorum. Vet Hum Toxicol 1996;38:280-282. (Pubitemid 26269442)
15. Park GJ, Mann SP, Ngu MC. Acute hepatitis induced by Shou-Wu-Pian, a herbal product derived from Polygonum multiflorum. J Gastroenterol Hepatol 2001;16:115-117. (Pubitemid 32120946)
16. Laird AR, Ramchandani N, deGoma EM, Avula B, Khan IA, Gesundheit N. Acute hepatitis associated with the use of an herbal supplement (Polygonum multiflorum) mimicking iron-overload syndrome. J Clin Gastroenterol 2008;42:861-862.
17. Mazzanti G, Battinelli L, Daniele C, et al. New case of acute hepatitis following the consumption of Shou Wu Pian, a Chinese herbal product derived from Polygonum multiflorum. Ann Intern Med 2004;140:W30.
18. Panis B, Wong DR, Hooymans PM, De Smet PA, Rosias PP. Recurrent toxic hepatitis in a Caucasian girl related to the use of Shou-Wu-Pian, a Chinese herbal preparation. J Pediatr Gastroenterol Nutr 2005;41:256-258. (Pubitemid 41099378)
19. Cárdenas A, Restrepo JC, Sierra F, Correa G. Acute hepatitis due to shen-min: a herbal product derived from Polygonum multiflorum. J Clin Gastroenterol 2006;40:629-632. (Pubitemid 44259771)
20. Cho HC, Min HJ, Ha CY, et al. Reactivation of pulmonary tuberculosis in a patient with Polygonum multiflorum Thunb-induced hepatitis. Gut Liver 2009;3:52-56.
21. Maria VA, Victorino RM. Development and validation of a clinical scale for the diagnosis of drug-induced hepatitis. Hepatology 1997;26:664-669. (Pubitemid 27392358)
22. Bénichou C. Criteria of drug-induced liver disorders: report of an international consensus meeting. J Hepatol 1990;11:272-276.
23. Rochon J, Protiva P, Seeff LB, et al. Reliability of the Roussel Uclaf Causality Assessment Method for assessing causality in drug-induced liver injury. Hepatology 2008;48:1175-1183.
24. Rockey DC, Seeff LB, Rochon J, et al. Causality assessment in drug-induced liver injury using a structured expert opinion process: comparison to the Roussel-Uclaf causality assessment method. Hepatology 2010;51:2117-2126.
25. Eisenberg DM, Kessler RC, Foster C, Norlock FE, Calkins DR, Delbanco TL. Unconventional medicine in the United States: prevalence, costs, and patterns of use. N Engl J Med 1993;328:246-252. (Pubitemid 23035311)
26. Kessler RC, Davis RB, Foster DF, et al. Long-term trends in the use of complementary and alternative medical therapies in the United States. Ann Intern Med 2001;135:262-268. (Pubitemid 32799340)
27. de Witte P, Lemli L. The metabolism of anthranoid laxatives. Hepatogastroenterology 1990;37:601-605.
28. Lucena MI, García-Cortés M, Cueto R, Lopez-Duran J, Andrade RJ. Assessment of drug-induced liver injury in clinical practice. Fundam Clin Pharmacol 2008;22:141-158. (Pubitemid 351392952)
29. Ernst E. Risks of herbal medicinal products. Pharmacoepidemiol Drug Saf 2004;13:767-771. (Pubitemid 39496898)